Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592821 | SCV000707568 | uncertain significance | not provided | 2017-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086237 | SCV001026676 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000592821 | SCV001778105 | likely benign | not provided | 2021-10-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000592821 | SCV002586195 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Ambry Genetics | RCV002331022 | SCV002639655 | likely benign | Cardiovascular phenotype | 2019-10-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001701097 | SCV003934791 | benign | not specified | 2023-05-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001701097 | SCV001924870 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000592821 | SCV001955479 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003945423 | SCV004762089 | likely benign | FLNC-related disorder | 2021-01-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |